Global Colon Cancer Association shared on LinkedIn:
“Clinical trials don’t just change the future for one disease. They can create breakthroughs across many.
In this clip, Dr. John Strickler explains how research in HER2-positive breast cancer helped pave the way for new treatment options for people with HER2-positive colorectal cancer.
Every clinical trial adds to our understanding of cancer. Sometimes those discoveries benefit patients far beyond the group the research originally set out to help.
Progress is built on participation, collaboration, and years of research.
Watch the clip to learn how advances in one cancer can lead to new possibilities in another.”
Other articles about colorectal cancer on OncoDaily.